Skip to content
Search

Latest Stories

India hails 'life saving' Covid-19 vaccine rollout

India hails 'life saving' Covid-19 vaccine rollout

India's Covid-19 vaccination drive had a successful start with more than 224,000 people receiving their first jabs and just three people hospitalised for experiencing side effects, the health ministry said Sunday, as reports emerged about concerns over a homegrown vaccine.

Authorities have given emergency-use approval for two jabs -- "Covishield", a version of the Oxford-AstraZeneca vaccine, and the Indian-made "Covaxin", which has yet to complete its Phase 3 trials.


The government plans to immunise some 300 million people out of its population of 1.3 billion by July.

Frontline workers such as hospital staff, people over 50 and those deemed to be at high risk due to pre-existing medical conditions are on the shortlist to receive the vaccines.

"We have got encouraging and satisfactory feedback results on the first day," health minister Harsh Vardhan told his state counterparts on Saturday.

"This vaccine will indeed be a 'Sanjeevani' (life saver)" in the fight against the virus, he added.

The health ministry said Sunday that 447 people reported experiencing side effects -- mostly fever, headache and nausea -- after being given their shot, with three people admitted to hospital.

Two have already been discharged, the ministry added.

Just six states carried out vaccinations on Sunday, the second day of the rollout. The government has advised local authorities to limit inoculations to four days a week so as to reduce disruptions to routine health services.

- Vaccine fears -

The updated vaccination figures came as a doctors' representative body at the Dr Ram Manohar Lohia Hospital in New Delhi wrote a letter asking for the Covishield vaccine to be supplied instead of Covaxin.

"The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination," said the letter addressing the hospital's medical superintendent, seen by AFP.

"We request you to vaccinate us with Covishield, which has completed all stages of trial before its rollout."

Pathologist Arvind Ahuja told AFP at the hospital on Saturday that he shared some of the concerns.

"I hope when the data comes out, it is good. Ideally, they should have waited for one month at least as then we would have known better about its efficacy," the 45-year-old said.

Vaccine hesitancy has emerged as a major concern, with a recent survey of 18,000 people across India finding that 69 percent were in no rush to get a shot.

Leading scientists and doctors have called on authorities to release efficacy data about Covaxin to boost confidence about the vaccine.

Covaxin recipients on Saturday had to sign a consent form that stated its "clinical efficacy... is yet to be established".

Officials had hoped to inoculate 300,000 people on Saturday but said glitches with an app used to coordinate and monitor the process meant not all potential recipients were alerted.

India has the world's second-largest known caseload with more than 10.5 million coronavirus infections and over 152,000 deaths so far.

More For You

Donald Trump

The latest tariffs are part of Trump’s broader effort to address what he claims are unfair trade practices

Getty

Trump pressures UK to accept chlorinated chicken for tariff relief

Britain is facing renewed pressure from the United States to lift its ban on chlorinated chicken as a condition for tariff relief, following the imposition of sweeping new trade barriers by Donald Trump’s administration. The US president has introduced a 10 per cent tariff on all British exports to the United States, with even steeper levies placed on imports from the European Union.

US tariffs and trade demands

The latest tariffs are part of Trump’s broader effort to address what he claims are unfair trade practices. The White House, in its announcement, criticised the UK’s “non-science-based standards” that restrict American agricultural imports, including poultry and beef. It argued that these trade policies act as non-tariff barriers that disadvantage US exporters.

Keep ReadingShow less
8 packaged foods recalled in UK in the last month

These food recalls show how important it is to check labels and stay updated on safety alerts

iStock

8 packaged foods recalled in UK in the last month

Food recalls in the UK are issued when products pose risks to consumers. These risks can range from contamination to allergen mislabelling, and staying informed about these recalls is crucial for consumer safety. Recent recalls emphasize the importance of vigilance when purchasing and consuming food items. If you’ve recently stocked up on groceries, it’s time to check your pantry and fridge to ensure none of the items listed below are affected.

1. Tony’s Chocolonely Chocolate Bars

On April 2, 2025, Tony’s Chocolonely recalled its Dark Almond Sea Salt & Everything Bar after discovering small stones in the product. The presence of foreign objects in food can pose serious risks, such as dental damage or choking hazards. The company has urged customers to return the affected items immediately to avoid potential harm. If you have recently purchased this product, check your packaging and return it to the store where it was bought for a full refund.

Keep ReadingShow less
Priyanka Chopra’s Skincare Secret for a Radiant Glow

A glimpse into the secret behind her flawless, dewy glow

Instagram/ priyankachopra

Priyanka Chopra shares her skincare secret for achieving the ultimate glow

Global icon Priyanka Chopra Jonas has once again mesmerized fans, not just with her undeniable star power but also with her radiant beauty and touching personal moments. The actress recently took to social media to unveil her simple yet effective skincare ritual, offering a glimpse into the secret behind her flawless, dewy glow.

A glow that speaks volumes

Priyanka’s skincare revelation came via her Instagram stories, where she showcased the results of her go-to beauty practice, a sheet mask. The actress shared snapshots flaunting her luminous complexion post-skincare, proving that sometimes, the simplest routines yield the most stunning results.

Keep ReadingShow less
Meghan Markle

Meghan remains optimistic about the future of her brand

Getty

Meghan Markle’s ‘As Ever’ products sell out in just 30 minutes, including £21.60 honey jars

Meghan Markle’s latest business venture, the As Ever lifestyle range, has made a remarkable debut, with products selling out in under 30 minutes. The highly anticipated collection, which features a selection of premium artisanal goods, has garnered immediate consumer interest and social media excitement.

Among the standout products was a jar of wildflower honey with honeycomb, priced at $28 (£21.60), which quickly disappeared from the online store. Other sought-after items included flower sprinkles at $15 (£11.60), raspberry jam at $14 (£10.80), and a selection of herbal teas and baking mixes, each ranging between $12 (£9.30) and $14 (£10.80). The rapid sell-out reflects Meghan’s growing influence in the lifestyle and wellness market.

Keep ReadingShow less
Kareena Kapoor

Striking appearance at the Vivienne Westwood show

Instagram/ kareenakapoorkhan

Kareena Kapoor dazzles in red at Vivienne Westwood show in Mumbai

Bollywood star Kareena Kapoor made a striking appearance at the Vivienne Westwood show in Mumbai on Tuesday evening, turning heads in a glamorous red ensemble. The event, held at the iconic Gateway of India, was a celebration of India’s rich textile heritage and featured an exclusive showcase of Vivienne Westwood’s Spring-Summer 2025 collection.

A show-stopping look

Kareena Kapoor, known for her impeccable fashion sense, was the cynosure of all eyes as she arrived in a stunning red gown featuring a thigh-high slit, corset bodice, and off-shoulder sleeves. Her outfit exuded elegance and sophistication, complemented by her gold-hued heels, which added a touch of glamour to her look.

Keep ReadingShow less